市場調査レポート

商品コード

1448236

乱用薬物検査の世界市場規模、シェア、成長分析、薬物別、サンプル別 - 産業予測2024～2031年

Global Drug of Abuse Testing Market Size, Share, Growth Analysis, By Drug(Alcohol, Cocaine), By Sample(Urine, Saliva) - Industry Forecast 2024-2031

出版日: 2024年03月05日 | 発行: SkyQuest

| ページ情報: 英文 198 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 834,909円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 976,686円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,118,463円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.53円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の乱用薬物検査の市場規模は、2022年に67億米ドルとなり、予測期間中（2024年～2031年）のCAGRは6.3%で、2023年の71億2,000万米ドルから、2031年までには116億1,000万米ドルに成長する見通しです。

世界の乱用薬物検査市場は、薬物乱用の蔓延の増加、産業における薬物検査に対する厳しい規制、ヘルスケアや職場環境における薬物検査の重要性に対する意識の高まりなどの要因によって大きな成長を遂げています。同市場は、国連薬物犯罪事務所による「世界薬物報告書」で約2億5,500万人の使用者が報告されるなど、薬物乱用を検出・防止するための薬物検査サービスに対する需要の高まりに後押しされています。薬物検査に対する認識と組織のコンプライアンスを促進する政府の取り組みも、市場拡大に寄与しています。しかし、少量の特定の薬物を正確に検出できない検査製品や、嗜好品や違法薬物の使用を合法化する法律の改正が市場の需要に与える影響などの課題もあります。課題はあるもの、免疫測定法、クロマトグラフィー、分子診断法などの検査技術の進歩により、検査の感度、特異性、精度が向上し、市場は成長機会をもたらしています。薬物検査が他のヘルスケアサービスと統合され、経口液検査の需要が増加していることも、市場の成長をさらに後押ししています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

乱用薬物検査の世界市場：薬物別

市場概要
アルコール
コカイン
マリファナ/大麻
LSD
オピオイド
その他

乱用薬物検査の世界市場：サンプル別

市場概要
尿
唾液
血
髪
呼吸
その他

乱用薬物検査の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Abbott Laboratories（US）
Thermo Fisher Scientific Inc.（US）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Alere Inc.（US）
Quest Diagnostics Incorporated（US）
Bio-Rad Laboratories, Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Biomerieux SA（France）
Shimadzu Corporation（Japan）
Randox Laboratories Ltd.（United Kingdom）
Psychemedics Corporation（US）
Sonic Healthcare（Australia）
Merck KGaA（Germany）
LabCorp（US）
MP Biomedicals LLC（US）
Omega Laboratories, Inc.（US）
Express Diagnostics International Inc.（US）
Sciteck, Inc.（US）
Premier Biotech Inc.（US）

Product Code: SQMIG30A2015

Global Drug of Abuse Testing Market size was valued at USD 6.7 Billion in 2022 and is poised to grow from USD 7.12 Billion in 2023 to USD 11.61 Billion by 2031, at a CAGR of 6.3% during the forecast period (2024- 2031).

The global drug of abuse testing market is witnessing significant growth driven by factors such as the increasing prevalence of substance abuse, stringent regulations for drug testing in industries, and growing awareness about drug testing's importance in healthcare and workplace settings. The market is propelled by rising demand for drug testing services to detect and prevent substance abuse, with approximately 255 million users reported in the World Drug Report by the United Nations Office on Drugs and Crime. Government initiatives promoting awareness and organizational compliance for drug testing also contribute to market expansion. However, challenges include the inability of testing products to detect small amounts of certain drugs accurately and the impact of changing laws legalizing recreational or illicit drug use on market demand. Despite challenges, the market offers growth opportunities driven by technological advancements in testing technologies like immunoassays, chromatography, and molecular diagnostics, enhancing testing sensitivity, specificity, and accuracy. Integration of drug testing with other healthcare services and increasing demand for oral fluid testing further drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug of Abuse Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug of Abuse Testing Market Segmental Analysis

The global drug abuse testing market is segmented on the basis of drug, sample, and region. By drug, the market is segmented into alcohol, cocaine, marijuana/cannabis, LSD, opioids, and others. By sample, the market is segmented into Urine, Saliva, Blood, Hair, Breath, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Drug of Abuse Testing Market

The growing production, consumption, and trade of both new and illicit drugs are expected to drive the demand for Drug of Abuse (DoA) testing, thus fueling the industry's growth. According to the United Nations Office on Drugs and Crime's World Drug Report 2017, there was an annual prevalence of 5.3% for illicit drug use, with 255 million users in 2015. This significant number of drug users underscores the necessity for DoA testing, which will propel the market forward. Government initiatives aimed at raising awareness about drug abuse and increasing organizational compliance for DoA testing will also contribute to the overall growth of the market. Additionally, there is a high demand for testing products that offer enhanced specificity and sensitivity to detect designer drugs, further bolstering the industry's expansion.

Restraints in the Global Drug of Abuse Testing Market

The growth of the drugs of abuse (DOA) testing market may face restraints due to limitations in current testing products detecting small amounts of specific drugs. Additionally, the transformation of laws to legalize recreational or illicit drugs is expected to pose a challenge during the forecast period of 2024-2031. This report on the DOA testing market provides comprehensive information on recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and local market players, emerging revenue opportunities, changes in market regulations, strategic growth analysis, market size, category market growth, application niches, product approvals, product launches, geographic expansions, and technological innovations. For more detailed information on the DOA testing market, you can contact Data Bridge Market Research for an Analyst Brief, where their team will assist you in making informed decisions to achieve market growth.

Market Trends of the Global Drug of Abuse Testing Market

There is a growing trend towards point-of-care testing, which enables quick and convenient drug testing at the bedside or in non-laboratory settings. This trend is fueled by the demand for rapid results and the capability to perform tests in remote or decentralized locations.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Drug of Abuse Testing Market by Drug

Market Overview
Alcohol
Cocaine
Marijuana/Cannabis
LSD
Opioids
and Others.

Global Drug of Abuse Testing Market by Sample

Market Overview
Urine
Saliva
Blood
Hair
Breath
and Others

Global Drug of Abuse Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MP Biomedicals LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Express Diagnostics International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Biotech Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments